Opticyte, Inc.
Biotechnology company · Seattle, Washington, United States
Opticyte, Inc. is a biotechnology company headquartered in Seattle, Washington, United States. Its earliest recorded incorporation is in 2016. It has received 3 US government small-business research awards (SBIR/STTR) from health agencies, $4 million in total, most recently in 2020. It has reported private securities offerings to the US SEC, most recently $72,250 sold in a notice filed in 2017.
Opticyte at a glance
What does Opticyte do?
US government research funding
3 SBIR/STTR small-business research awards from US health agencies, $4 million in total (2015 to 2020). NIH funding came from the National Heart, Lung, and Blood Institute.
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $72,250 sold (2017).
Frequently asked questions about Opticyte
Where is Opticyte headquartered?
Opticyte, Inc. is headquartered in Seattle, Washington, United States.
What does Opticyte do?
Opticyte, Inc. is a biotechnology company.
When was Opticyte founded?
The earliest incorporation on record for Opticyte, Inc. is in 2016, according to public company registers.
Similar companies
- Adaptive Biotechnologies CorpSeattle, Washington, United States
- Kineta, Inc.Seattle, Washington, United States
- Avm Biotechnology, LLCSeattle, Washington, United States
- Lumen Bioscience, Inc.Seattle, Washington, United States
- Presage Biosciences, Inc.Seattle, Washington, United States
- Sana Biotechnology, Inc.Seattle, Washington, United States
- Phase Genomics, Inc.Seattle, Washington, United States
- Soovu Labs, Inc.Seattle, Washington, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences